venBio Global Strategic GP II, Ltd., 10% Owner at Akero Therapeutics, Inc. (AKRO), bought 3,719,759 shares at $16.00 ($4.0M) on 2019-06-24, disclosed to the SEC on 2019-06-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 3,469,759 | $0 | 0.0% |
| 2 | $16.00 | 250,000 | $4.0M | 100.0% |
| Total | $1.08 avg | 3,719,759 | $4.0M | 100% |
| Filing → |
| CMPI | BUY | 2020-08-12 | $3.0M | — | Filing → |